Which are the causes of Uveitis?

Uveitis is an inflammation of the uvea, the middle layer of the eye, which can be triggered by autoimmune disorders, infections, trauma, or specific genetic predispositions. While the exact cause remains idiopathic—meaning unknown—in approximately 30% to 50% of cases, medical research increasingly points to complex interactions between the immune system and environmental triggers.

What are the primary causes of Uveitis?

The causes of Uveitis are diverse because the condition is an inflammatory response rather than a single disease entity. Clinically, we categorize these into four main buckets: autoimmune/inflammatory diseases (such as sarcoidosis or ankylosing spondylitis), infections (like tuberculosis, syphilis, or herpes simplex), trauma or injury to the eye, and idiopathic cases where the underlying mechanism remains unidentified. In the Uveitis community on DiseaseMaps.org, our 135 members often highlight how the inflammation can be localized to the front (anterior), middle (intermediate), or back (posterior) of the eye, which helps physicians narrow down the potential cause.

Is Uveitis hereditary or genetic?

While Uveitis is not strictly "hereditary" in the sense of a single-gene mutation, there is a significant genetic component related to the immune system. The most well-known association is with the HLA-B27 gene. Individuals carrying the HLA-B27 antigen have a much higher risk of developing anterior Uveitis, often linked to systemic conditions like reactive arthritis or ankylosing spondylitis. Think of this gene as a "molecular key" that makes the immune system more prone to overreacting to internal or external triggers, leading to the inflammation seen in Uveitis.

What are the risk factors and environmental triggers?

It is important to distinguish between a cause (the direct agent of disease) and a risk factor (a condition that increases susceptibility). Environmental factors and systemic triggers play a major role in the onset of Uveitis. Common factors include:

• Infectious exposure: Bacteria, viruses, fungi, or parasites that enter the body or the eye directly.


• Systemic inflammatory diseases: Conditions like Behçet’s disease or Inflammatory Bowel Disease (IBD).


• Smoking: Evidence suggests that smoking acts as a significant risk factor, potentially worsening the inflammatory process in patients with Uveitis.


• Physical trauma: Blunt or penetrating eye injuries can trigger a localized inflammatory response.

How is current research improving our understanding?

Current research into Uveitis is shifting toward the study of the "microbiome-eye axis." Researchers are investigating how gut bacteria may influence the immune system’s behavior in the eye. Furthermore, advancements in genomic sequencing are helping us identify rare genetic variants that cause "white dot syndromes" and other specific subtypes of Uveitis. While we have made significant progress, the field is still working to decode why some patients experience chronic, recurrent inflammation while others experience only a single, self-limiting episode.

Next steps

• Consult an ophthalmologist specializing in uveitis (a uveitis specialist) to determine if your inflammation is linked to a systemic condition.


• Undergo a comprehensive blood panel and, if necessary, imaging tests to rule out infectious or systemic autoimmune causes.


• Join the Uveitis community on DiseaseMaps.org to connect with others and share experiences regarding diagnosis and treatment paths.


• Keep a symptom journal to track potential triggers, such as stress, diet, or environmental allergies, to discuss with your care team.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Uveitis Overview.


• Orphanet: Rare eye diseases and uveitis classification.


• American Uveitis Society: Clinical practice guidelines and patient resources.


• PubMed: Recent studies on HLA-B27 and ocular inflammation (2022-2024 literature).